New Trends in Vaccine Manufacture - From Egg to Bioreactor - METTLER TOLEDO
White Paper

New Trends in Vaccine Manufacture - From Egg to Bioreactor

White Paper
From Egg to Bioreactor
From Egg to Bioreactor

Increasing worldwide demand for vaccines is resulting in manufacturers changing their production methods. Slow, chicken egg-based techniques are being replaced by much faster mammalian cell-culture fermentation. This white paper outlines vaccine manufacture based on biotechnology, and discusses the important role of the latest process analytical technology in maximizing production yield.

Find out:

  • how control of pH, dissolved oxygen, and dissolved CO2 levels affect mammalian cell culture productivity
  • the importance of analytical measurements in downstream processes
  • a recent development in sensor technology that increases fermentation process reliability

 

 
 
 
 
 
 
 
Thank you for visiting www.mt.com. We have tried to optimize your experience while on the site, but we noticed that you are using an older version of a web browser. We would like to let you know that some features on the site may not be available or may not work as nicely as they would on a newer browser version. If you would like to take full advantage of the site, please update your web browser to help improve your experience while browsing www.mt.com.